Published in Front Immunol on September 11, 2015
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci (2016) 0.76
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol (2013) 3.03
A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol (1998) 2.74
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis (1998) 2.42
A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3. Nature (2014) 2.33
The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 1.97
Role of plant polyphenols in genomic stability. Mutat Res (2001) 1.56
The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol (2012) 1.54
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol (2014) 1.53
Multi-omics analysis of inflammatory bowel disease. Immunol Lett (2014) 1.44
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology (2015) 1.42
Inflammatory disease processes and interactions with nutrition. Br J Nutr (2009) 1.34
Integrative analysis of the microbiome and metabolome of the human intestinal mucosal surface reveals exquisite inter-relationships. Microbiome (2013) 1.32
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 1.29
High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet (2015) 1.27
Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology (2013) 1.24
Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res (2012) 1.18
Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Curr Opin Biotechnol (2014) 1.16
Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care (2010) 1.07
Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One (2012) 1.06
The Micronutrient Genomics Project: a community-driven knowledge base for micronutrient research. Genes Nutr (2010) 1.06
Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. World J Gastroenterol (2014) 1.05
Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol (2003) 1.05
Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol (2014) 1.04
The emerging role of miRNAs in inflammatory bowel disease: a review. Therap Adv Gastroenterol (2015) 1.03
Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. J Proteome Res (2011) 1.01
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol (2015) 0.99
Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. J Gastroenterol Hepatol (2015) 0.98
Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn's disease patients. Hum Genomics (2013) 0.98
Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res (2009) 0.97
Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res (2014) 0.97
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol (2015) 0.97
Using metabolomic analysis to understand inflammatory bowel diseases. Inflamm Bowel Dis (2011) 0.96
Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J Proteome Res (2010) 0.96
Genome-wide analysis of dietary eicosapentaenoic acid- and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. J Nutrigenet Nutrigenomics (2008) 0.95
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2014) 0.95
Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut (2014) 0.95
Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3. J Nutr (2011) 0.95
Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease? Crit Rev Food Sci Nutr (2014) 0.95
NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids. Atherosclerosis (2010) 0.94
Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies. World J Gastroenterol (2014) 0.93
Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol (2010) 0.93
The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr (2008) 0.92
Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. Am J Clin Nutr (2010) 0.92
Toward a road map for global -omics: a primer on -omic technologies. Am J Epidemiol (2014) 0.89
Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: a randomized clinical trial. Nutrition (2011) 0.89
EPA and DHA exposure alters the inflammatory response but not the surface expression of Toll-like receptor 4 in macrophages. Lipids (2014) 0.88
Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. Br J Nutr (2007) 0.88
Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res (2010) 0.88
Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med (2014) 0.88
Dissecting high from low responders in a vitamin D3 intervention study. J Steroid Biochem Mol Biol (2014) 0.87
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals. Metabolomics (2014) 0.87
Cascades of genetic instability resulting from compromised break-induced replication. PLoS Genet (2014) 0.87
Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther (2013) 0.87
Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr (2014) 0.86
Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol (2014) 0.85
Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.85
Proteomic analysis of colon tissue from interleukin-10 gene-deficient mice fed polyunsaturated Fatty acids with comparison to transcriptomic analysis. J Proteome Res (2011) 0.85
Systems biology in inflammatory bowel diseases: ready for prime time. Curr Opin Gastroenterol (2014) 0.84
Nutritional management of Crohn's disease. Therap Adv Gastroenterol (2013) 0.84
Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways. Biochem Biophys Res Commun (2014) 0.83
Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms. Mol Nutr Food Res (2013) 0.83
Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases. Chem Res Toxicol (2015) 0.83
Nutrigenetics, nutrigenomics and inflammatory bowel diseases. Expert Rev Clin Immunol (2013) 0.82
Determination of the discriminant score of intestinal microbiota as a biomarker of disease activity in patients with ulcerative colitis. BMC Gastroenterol (2014) 0.82
Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr Cancer (2013) 0.82
Anti-inflammatory activity of fruit fractions in vitro, mediated through toll-like receptor 4 and 2 in the context of inflammatory bowel disease. Nutrients (2014) 0.82
EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation. Int J Clin Exp Pathol (2014) 0.82
Dietary oleic acid as a control fatty acid for polyunsaturated fatty acid intervention studies: a transcriptomics and proteomics investigation using interleukin-10 gene-deficient mice. Biotechnol J (2010) 0.81
Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr (2014) 0.81
Nutrigenetics, nutrigenomics, and selenium. Front Genet (2011) 0.81
Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. Clin Nutr (2010) 0.81
Effects on varying intravenous lipid emulsions on the small bowel epithelium in a mouse model of parenteral nutrition. JPEN J Parenter Enteral Nutr (2013) 0.80
Curcumin inhibits the AKT/NF-κB signaling via CpG demethylation of the promoter and restoration of NEP in the N2a cell line. AAPS J (2014) 0.80
Modulation of colonic inflammation in Mdr1a(-/-) mice by green tea polyphenols and their effects on the colon transcriptome and proteome. J Nutr Biochem (2013) 0.80
Effect of dietary supplementation of (-)-epigallocatechin gallate on gut microbiota and biomarkers of colonic fermentation in rats. J Nutr Sci Vitaminol (Tokyo) (2014) 0.79
The role of Vitamin D level and related single nucleotide polymorphisms in Crohn's disease. Nutrients (2013) 0.79
1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells. J Steroid Biochem Mol Biol (2014) 0.78
The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea. Scand J Gastroenterol (2014) 0.78
Candidate genes involved in beneficial or adverse responses to commonly eaten brassica vegetables in a New Zealand Crohn's disease cohort. Nutrients (2013) 0.78
Prebiotics Modulate the Effects of Antibiotics on Gut Microbial Diversity and Functioning in Vitro. Nutrients (2015) 0.78
The Low FODMAP Diet for Treatment of Irritable Bowel Syndrome and Other Gastrointestinal Disorders. Gastroenterol Hepatol (N Y) (2013) 0.78
Metabolomic analysis reveals differences in urinary excretion of kiwifruit-derived metabolites in a mouse model of inflammatory bowel disease. Mol Nutr Food Res (2011) 0.78
Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells. Anticancer Res (2015) 0.78
Nutriomes and nutrient arrays - the key to personalised nutrition for DNA damage prevention and cancer growth control. Genome Integr (2010) 0.78
Integrating omics: the future of IBD? Dig Dis (2014) 0.77
Effect of prebiotics on biomarkers of colorectal cancer in humans: a systematic review. Nutr Rev (2012) 0.77
Dietary interactions with the bacterial sensing machinery in the intestine: the plant polyphenol case. Front Genet (2014) 0.77
Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease. J Pediatr Hematol Oncol (2015) 0.77
Nutriomes and personalised nutrition for DNA damage prevention, telomere integrity maintenance and cancer growth control. Cancer Treat Res (2014) 0.77
Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.77
Inflammatory bowel disease among Bedouin Arabs in southern Israel: urbanization and increasing prevalence rates. Eur J Gastroenterol Hepatol (2015) 0.76
Tailoring foods to match people's genes in New Zealand: opportunities for collaboration. J Nutrigenet Nutrigenomics (2011) 0.76
JAK2 and AMP-kinase inhibition in vitro by food extracts, fractions and purified phytochemicals. Food Funct (2014) 0.76
The impact of network medicine in gastroenterology and hepatology. Clin Gastroenterol Hepatol (2013) 0.76
COMMENTARY. Pre-emptive Nutrition: Refining the Targets of Drugs Targeted to Colorectal Cancer. Curr Cancer Drug Targets (2015) 0.76
Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort. J Gastrointestin Liver Dis (2012) 0.76